Enzymedica develops an RTD formula to nourish intermittent fasters
14 Jun 2024 --- US-based dietary supplement manufacturer Enzymedica launched Fasting Today, a ready-to-drink (RTD) formula that meets the nutritional needs of intermittent fasters with essential ingredients such as electrolytes, fiber and amino acids.
"We understand the growing interest in intermittent fasting and the importance of feeling your best during fasting periods,” says Ryan Sensenbrenner, senior director of marketing at Enzymedica.
“With Fasting Today, we aim to provide a comprehensive product that enhances this experience and empowers individuals to achieve their health goals with confidence.”
Enzymedica formulated Fasting Today to support people who practice time-restricted dieting with added nutrients that are essential during fasting periods. The formula contains baobab fiber to reduce hunger. Amino acids facilitate muscle strength and body composition, and electrolytes hydrate and support cardiovascular and brain health.
Body reset
Intermittent fasting has become a widespread health practice with continued consumer interest. Many forms involve alternating fasting cycles and eating within a set number of hours; however, there are other ways to implement the process.
Research shows intermittent fasting supports weight management, increased energy levels, brain health and healthy aging.
Fasting Today is soy-free, dairy-free, gluten-free, keto-friendly and vegan. It contains no artificial flavors or colors. It has a tropical pineapple flavor and is available in a 24-serving format.
Enzymedica’s product range includes Digest Gold, a digestive enzyme formula and supplements for digestive health, occasional heartburn, metabolic balance and immune health.
In a recent independent research study, scientists suggested restricting calories is more important for weight loss than meal timing. They found no benefits for a time-restricted eating pattern over a usual one when calorie intake was constant. Experts support the outcomes of the randomized clinical trial but call for additional research to overcome its limitations, such as the small participant size, and examine differences in metabolic parameters.
Another study conducted at the University of Southern California, US, cycles of a fasting-mimicking diet may reduce insulin resistance, liver fat, immune system aging, and biological aging.
